CARD11 mutations in tumors were first reported in DLBCL in 2008 and transfer of the identified CARD11 coiled-coil domain mutants into lymphoma cell lines resulted in constitutive NF-κB activation (81). This evidence concerns the gene CARD11 and diffuse large B-cell lymphoma.